Efforts to vaccinate workers exposed to bird flu strain with potential mutations for global preparedness

From Investing.com: 2024-05-27 01:06:02

The U.S. and Europe are pursuing H5N1 bird flu vaccines to protect those at risk, such as poultry workers. U.S. officials are converting bulk vaccine to 4.8 million doses, while European health officials are discussing acquiring a prepandemic vaccine from CSL. Canadian officials are also in talks with GSK for a bird flu vaccine.

The new bird flu strain has caused widespread deaths in birds and domestic poultry, infecting other mammal species. In the U.S., the virus has spread to dairy cattle and two workers, alarming officials. Concerns are rising about human exposure leading to mutations that could facilitate human-to-human transmission.

Efforts are being made to prevent a potential pandemic, including discussions with U.S. and Canadian officials about vaccinating workers in close contact with infected animals. Vaccine contracts with CSL and GSK are in place to better match circulating H5N1 strains. Scientists globally are exploring prepandemic vaccine strategies.

European and U.S. officials are considering strategic deployment of H5N1 vaccines to high-risk populations. The European Commission aims to prevent a pandemic with joint vaccine procurement. Discussions involve potential shifts to producing pandemic flu vaccines and exploring mRNA vaccine options with Pfizer and Moderna for global preparedness.

In light of the severe threat posed by the bird flu virus, efforts are underway to acquire the necessary vaccines to protect at-risk populations. Staying ahead of potential mutations and efficient transmission is crucial for preventing a global health crisis.



Read more at Investing.com: US, European nations consider vaccinating workers exposed to bird flu By Reuters